Daniel Davison Joins Advanced Dermatology and Cosmetic Surgery as Chief Financial OfficerBusiness Wire • 10/05/20
Implied Volatility Surging for Diplomat Pharmacy (DPLO) Stock OptionsZacks Investment Research • 12/04/19
Diplomat Pharmacy Analysts Weigh Takeout Scenarios, Valuation After Going Concern WarningBenzinga • 11/13/19
Diplomat Pharmacy's (DPLO) CEO Brian Griffin on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/12/19
Diplomat Pharmaceuticals (DPLO) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/12/19
Diplomat Pharmacy's (DPLO) CEO Brian Griffin on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/09/19
Diplomat Pharmacy's stock climbs after potential sale considered as it reported a wider lossMarket Watch • 08/09/19
Analysts Estimate Diplomat Pharmaceuticals (DPLO) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 08/02/19
Diplomat Pharmacy, Inc. (DPLO) CEO Brian Griffin on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/07/19
Diplomat Pharmaceuticals (DPLO) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/07/19
Diplomat Pharmaceuticals (DPLO) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 04/30/19
Diplomat Pharmacy's Valuation Presents Value To A Strategic Buyer, Raymond James Says In UpgradeBenzinga • 03/21/19